Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-6148
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges ; volume:8 ; number:1 ; day:3 ; month:10 ; year:2012 ; pages:1-16 ; date:12.2012
BMC veterinary research ; 8, Heft 1 (3.10.2012), 1-16, 12.2012
- Urheber
-
Geldhof, Marc F.
- Beteiligte Personen und Organisationen
-
Vanhee, Merijn
Van Breedam, Wander
Van Doorsselaere, Jan
Karniychuk, Uladzimir U.
Nauwynck, Hans J.
SpringerLink (Online service)
- DOI
-
10.1186/1746-6148-8-182
- URN
-
urn:nbn:de:1111-2016080547915
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Geldhof, Marc F.
- Vanhee, Merijn
- Van Breedam, Wander
- Van Doorsselaere, Jan
- Karniychuk, Uladzimir U.
- Nauwynck, Hans J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Autogenous Vaccines
Comparative innocuity and efficacy of live and inactivated sheeppox vaccines
Immune response of horses to inactivated African horse sickness vaccines
Immune response of horses to inactivated African horse sickness vaccines
Genomic tailoring of autogenous poultry vaccines to reduce Campylobacter from farm to fork
Experimental study of the efficacy of three inactivated H9N2 influenza vaccines in broiler flocks
Safety of inactivated SARS-CoV-2 vaccines in patients with allergic diseases
Field results using autogenous vaccines in commercial layers to reduce E. coli infection
Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients
Development and efficacy testing of inactivated vaccines against Schmallenberg virus infection in cattle and sheep
Ensuring safety of DNA vaccines
Rational Design of AIDS Vaccines
Autogenous Vaccines
Comparative innocuity and efficacy of live and inactivated sheeppox vaccines
Immune response of horses to inactivated African horse sickness vaccines
Immune response of horses to inactivated African horse sickness vaccines
Genomic tailoring of autogenous poultry vaccines to reduce Campylobacter from farm to fork
Experimental study of the efficacy of three inactivated H9N2 influenza vaccines in broiler flocks
Safety of inactivated SARS-CoV-2 vaccines in patients with allergic diseases
Field results using autogenous vaccines in commercial layers to reduce E. coli infection
Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients
Development and efficacy testing of inactivated vaccines against Schmallenberg virus infection in cattle and sheep
Ensuring safety of DNA vaccines
Rational Design of AIDS Vaccines
Autogenous Vaccines
Comparative innocuity and efficacy of live and inactivated sheeppox vaccines
Immune response of horses to inactivated African horse sickness vaccines
Immune response of horses to inactivated African horse sickness vaccines
Genomic tailoring of autogenous poultry vaccines to reduce Campylobacter from farm to fork
Experimental study of the efficacy of three inactivated H9N2 influenza vaccines in broiler flocks
Safety of inactivated SARS-CoV-2 vaccines in patients with allergic diseases
Field results using autogenous vaccines in commercial layers to reduce E. coli infection
Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients
Development and efficacy testing of inactivated vaccines against Schmallenberg virus infection in cattle and sheep
Ensuring safety of DNA vaccines